Abstract

Background & aims:¬†Endpoints in randomized controlled trials (RCTs) of Crohn’s disease (CD) are changing. We performed a systematic review of efficacy and safety outcomes reported in placebo-controlled RCTs of patients with CD.

Tags

therapeutic use, Treatment Outcome, Adverse Effects, Therapy, Diagnosis, Anti-Inflammatory Agents, RCT, Effects, Inflammatory Bowel Disease, Treatment, IBD, Crohn's Disease

Read More